Tag Archive | "deal analysis"

Orphan Diseases: recent partnering deal trends

Tags: , ,


An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
Read the full story

Current Agreements Deals Update : February 2014

Tags: , , ,


This month we provide you with an overview of deal analysis life science deal making activity, covering partnering, M&A and financing in January 2014 Read the full story

Current Agreements Deals Update : January 2014

Tags: , , ,


This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in December 2013 Read the full story

Current Agreements Deal Analysis Update : December 2013

Tags: , , , ,


This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in November 2013 Read the full story

Current Agreements Deal analysis Update : October 2013

Tags: , , , ,


This month we are providing you with an overview of deal analysis in the life sciences, covering partnering and M&A in September 2013 Read the full story

Cardiovascular partnering – recent deal analysis 2007-2013

Tags: , ,


Partnering deal analysis in the last decade has seen an increase in cardiovascular partnering with an increase in modern diagnostic technologies Read the full story

Bioinformatics: recent life science partnering trend analysis

Tags: , , , ,


The bioinformatics life science partnering deal trends 2007 to 2013 are reviewed in this article Read the full story

Current Agreements Deal analysis Update : September 2013

Tags: , , , ,


This month we are providing you with an overview of deal analysis in the life sciences, covering partnering and M&A in August 2013 Read the full story

Big pharma and big biotech companies deal analysis – 2007 to 2013

Tags: , , ,


Partnering trends and deal analysis reviewed with over 4,000 deals entered by the world’s leading fifty big pharma and big biotech companies Read the full story

Current Agreements Deal analysis Update : June 2013

Tags: ,


This month we are providing you with an overview of deal analysis in the life sciences, covering partnering and M&A in May 2013 Read the full story

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
a1banner300x150animgif